Aspen Pharmacare has signed a deal with Indian firm Laurus for the supply of active pharmaceutical ingredients (APIs) which are used for making HIV/Aids drugs.
The deal with Laurus, which is one of the world’s largest API suppliers, will give the South African government access to competitively priced APIs, according to Aspen senior executive Stavros Nicolaou...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.